Besides, decreased expressions of MMP2 and MMP9 in HCT116 cells receiving eriodictyol treatment also suggested that eriodictyol could suppress CRC cell migration and invasion (Figure 2(c)). Here, MMP9 is linked to colorectal carcinoma.